MicroRNA-107 is a novel tumor suppressor targeting POU3F2 in melanoma
Biol. Res
;
53: 11, 2020. graf
Article
Dans Anglais
| LILACS
| ID: biblio-1100917
ABSTRACT
BACKGROUND:
Melanoma is one of the major types of skin cancer. The metastatic melanoma is among the most lethal forms of malignant skin tumors. We hereby aimed to characterize a novel microRNA (miR) in the metastatic melanoma model.METHODS:
First, we evaluated the expression of miR-107 in melanoma cells and tumor tissues. The comparison between primary and metastatic cancer tissues was also accessed. Next, we examined the impact of miR-107 on melanoma cell proliferation, cell cycle, colony formation, apoptotic activity, migration and matrix invasion. A downstream target of miR-107 was also predicted and validated functionally in melanoma cells.RESULTS:
Our findings showed miR-107 was significantly downregulated in melanoma. Its expression was lowest in metastatic form. Over-expression of miR-107 reduced melanoma cell proliferation, migration and invasion. POU3F2 was identified as the downstream target of miR-107. Over-expression of POU3F2 antagonized miR-107-mediated inhibitory effect on melanoma cells.CONCLUSION:
Our study has reported miR-107 as a novel tumor suppressive factor in the metastatic melanoma model. It has provided new avenue to manage melanoma and improve the survival rate in the advanced stage.
Texte intégral:
Disponible
Indice:
LILAS (Amériques)
Sujet Principal:
Régulation de l'expression des gènes tumoraux
/
Gènes suppresseurs de tumeur
/
MicroARN
/
Facteurs de transcription à domaine POU
/
Mélanome
Type d'étude:
Étude pronostique
Limites du sujet:
Humains
langue:
Anglais
Texte intégral:
Biol. Res
Thème du journal:
Biologie
Année:
2020
Type:
Article
Pays d'affiliation:
Chine
Institution/Pays d'affiliation:
Beijing University of Traditional Chinese Medicine/CN
/
Daqing Oilfield General Hospital/CN
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS